Huadong Medicine: Notice on Wholly-owned Subsidiaries Receiving Notice of Acceptance of Medical Device Registration Applications
00:00
Huadong Pharmaceutical: Announcement on Wholly-owned Subsidiaries Obtaining US FDA Clinical Trial Approval Notice for New Drugs
Apr 23 00:00
Huadong Pharmaceutical: 2023 Annual Financial Report
Apr 18 00:00
Huadong Pharmaceutical: Report on the performance of supervisory duties of accounting firms by the Board of Auditors in 2023
Apr 18 00:00
Huadong Pharmaceutical: Notice on Convening the 2023 Annual General Meeting of Shareholders
Apr 18 00:00
Huadong Pharmaceutical: 2023 Internal Control Self-Evaluation Report
Apr 18 00:00
Huadong Pharmaceutical: Notice on completing the registration and filing of industrial and commercial changes and issuing a business license
Apr 13 00:00
Huadong Pharmaceutical: Board Audit Committee Rules
Apr 10 00:00
Huadong Pharmaceutical: Announcement on the adjustment of the members of the Audit Committee of the 10th Board of Directors
Apr 10 00:00
Huadong Pharmaceutical: Notice on amending the “Articles of Association” and its annexes
Apr 10 00:00
Huadong Pharmaceutical: Board Nomination Committee Rules
Apr 10 00:00
Huadong Pharmaceutical: Board of Directors Rules of Procedure
Apr 10 00:00
Huadong Pharmaceutical: General Manager Work Rules
Apr 10 00:00
Huadong Pharmaceutical: Board Remuneration and Assessment Committee Rules of Procedure
Apr 10 00:00
Huadong Pharmaceutical: Board Secretary Work Rules
Apr 10 00:00
Huadong Pharmaceutical: Board Strategy Committee Rules of Procedure
Apr 10 00:00
East China Pharmaceutical: Accounting Services Selection and Employment System
Apr 10 00:00
Huadong Pharmaceutical: Announcement on adding and amending some company systems
Apr 10 00:00
Huadong Pharmaceutical: Foreign Investment Management System
Apr 10 00:00
Huadong Pharmaceutical: Board of Directors Sustainability (ESG) Committee Rules of Procedure
Apr 10 00:00
No Data
No Data